1. Home
  2. FUBO vs EVO Comparison

FUBO vs EVO Comparison

Compare FUBO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUBO
  • EVO
  • Stock Information
  • Founded
  • FUBO 2009
  • EVO 1993
  • Country
  • FUBO United States
  • EVO Germany
  • Employees
  • FUBO N/A
  • EVO N/A
  • Industry
  • FUBO Broadcasting
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUBO Industrials
  • EVO Health Care
  • Exchange
  • FUBO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • FUBO 1.3B
  • EVO 1.4B
  • IPO Year
  • FUBO 2020
  • EVO 2021
  • Fundamental
  • Price
  • FUBO $3.69
  • EVO $3.82
  • Analyst Decision
  • FUBO Buy
  • EVO Buy
  • Analyst Count
  • FUBO 5
  • EVO 2
  • Target Price
  • FUBO $5.35
  • EVO $5.40
  • AVG Volume (30 Days)
  • FUBO 21.1M
  • EVO 79.0K
  • Earning Date
  • FUBO 08-08-2025
  • EVO 08-13-2025
  • Dividend Yield
  • FUBO N/A
  • EVO N/A
  • EPS Growth
  • FUBO N/A
  • EVO N/A
  • EPS
  • FUBO 0.26
  • EVO N/A
  • Revenue
  • FUBO $1,625,738,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • FUBO N/A
  • EVO $1.13
  • Revenue Next Year
  • FUBO $9.69
  • EVO $9.67
  • P/E Ratio
  • FUBO $14.15
  • EVO N/A
  • Revenue Growth
  • FUBO 6.65
  • EVO N/A
  • 52 Week Low
  • FUBO $1.21
  • EVO $2.84
  • 52 Week High
  • FUBO $6.45
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • FUBO 48.51
  • EVO 43.94
  • Support Level
  • FUBO $3.50
  • EVO $3.74
  • Resistance Level
  • FUBO $3.87
  • EVO $3.98
  • Average True Range (ATR)
  • FUBO 0.30
  • EVO 0.09
  • MACD
  • FUBO -0.03
  • EVO -0.02
  • Stochastic Oscillator
  • FUBO 10.56
  • EVO 14.71

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: